NRXP
NRx Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
11.12 / 10
Outperform
Sentiment is highly positive (score 11.12) and fund‑flow rating is good (7.94). Overall inflow ratio is 0.53, though small‑, medium‑ and large‑cap flows are negative. Analyst consensus is 100% Strong‑Buy from two firms, reinforcing a bullish outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-17
InstitutionD. Boral Capital
Times predicted25
Historical Win Rate48.0%
What is the analyst consensus for NRXP?
- NRXP holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 11.12/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
